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Fostering the exchange of real world data across different
countries to answer primary care research questions: an
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Liza Cragg1, Siân Williams1, Thys van der Molen2, Mike Thomas3, Jaime Correia de Sousa 4 and Niels H. Chavannes 5
There is growing awareness amongst healthcare planners, providers and researchers of the need to make better use of routinely
collected health data by translating it into actionable information that improves efficiency of healthcare and patient outcomes.
There is also increased acceptance of the importance of real world research that recruits patients representative of primary care
populations and evaluates interventions realistically delivered by primary care professionals. The UNLOCK Group is an international
collaboration of primary care researchers and practitioners from 15 countries. It has coordinated and shared datasets of diagnostic
and prognostic variables for COPD and asthma to answer research questions meaningful to professionals working in primary care
over a 6-year period. Over this time the UNLOCK Group has undertaken several studies using data from unselected primary care
populations from diverse contexts to evaluate the burden of disease, multiple morbidities, treatment and follow-up. However,
practical and structural constraints have hampered the UNLOCK Group’s ability to translate research ideas into studies. This study
explored the constraints, challenges and successes experienced by the UNLOCK Group and its participants’ learning as researchers
and primary care practitioners collaborating to answer primary care research questions. The study identified lessons for future
studies and collaborations that require data sharing across borders. It also explored specific challenges to fostering the exchange of
primary care data in comparison to other datasets such as public health, prescribing or hospital data and mechanisms that may be
used to overcome these.
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INTRODUCTION
The founding ambitions of the International Primary Care
Respiratory Group (IPCRG) in 2000 included sharing data across
countries to understand the real world similarities and differences
in primary care management of chronic respiratory disease in
different countries and to create large longitudinal datasets more
rapidly.1 The UNLOCK Group (uncovering and noting long-term
outcomes in chronic obstructive pulmonary disease (COPD) and
asthma to enhance knowledge) is one of the projects IPCRG
members established to achieve this ambition. It is an on-going
international collaboration between primary care researchers and
practitioners to coordinate and share datasets of relevant
diagnostic and prognostic variables for COPD and asthma
management, which began in 2010. It builds on the IPCRG’s
published research needs, which called for research that evaluates
interventions realistically delivered within primary care and draws
conclusions meaningful to professionals working within primary
care.2,3 The UNLOCK Group summary protocol was published in
the Primary Care Respiratory Journal in 2010.4
This study explored the lessons from 6 years of the UNLOCK
Group’s collaboration through: structured telephone interviews
with key informants; an online questionnaire for participants using
Survey Monkey; analysis of key documents the collaboration
produced; and analysis of the datasets to which participants had
access. The study methods are explained in more detail in the
methods section which is situated after the discussion section.
The objectives of the study were:
1. To describe and classify the successes and motivation of
participants in the UNLOCK Group in seeking to share real
world data across regional and country borders to answer
research questions and how these have been captured/built
upon;
2. To describe and classify the constraints experienced by
participants in the UNLOCK Group in seeking to share real
world data across regional and country borders to answer
research questions and how these have been overcome;
3. To identify methods to improve the effectiveness of future
studies involving data sharing across countries to inform
future research collaborations;
4. To describe other impacts of the UNLOCK Group, including
the development of electronic recording systems, data
validation and data extraction.
RESULTS
Development of the UNLOCK Group and its participants
The first meeting of the UNLOCK Group took place in September
2010. At this meeting, the UNLOCK Group outlined a protocol
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summary which was then finalised and published.5 Key milestones
in the UNLOCK Group’s development are described in Table 1.
Early meetings were organised and financed by the IPCRG. The
IPCRG Executive Officer also provided support for fundraising and
for the development of a governance mechanism for UNLOCK.
This governance mechanism provided the IPCRG Board with
overall responsibility of the UNLOCK Group’s progress and
performance, both financially and scientifically. Two consecutive
unrestricted grants from Novartis enabled the UNLOCK Group to
appoint a part-time project manager from January 2013 to May
2016 and part-time researcher from March 2014 to March 2016.
From 2013 an IPCRG Steering Committee provided leadership and
progress oversight. The UNLOCK Group continued to meet in
person biannually.
Participation in the UNLOCK Group was initially conceived as
being limited to members who could contribute primary care
patient data on COPD that met inclusion criteria and extended to
include primary care patient data on asthma in 2012. However, in
practice individuals participated in meetings even if they did not
have access to a database. Therefore, participation has been and
continues to be based on interest in the work of the UNLOCK
Group. Over the first 6 years approximately 26 individuals from 15
countries participated in the UNLOCK Group’s work. Table 2 lists
these participants. Thirteen of the participants have a combined
research/academic and clinical role, 10 have a research/academic
role only and three have a clinical role only.
The data used by the UNLOCK Group
An analysis of datasets shows that by early 2016 participants in the
UNLOCK Group had access to 14 datasets compared to 10
datasets available when the Group was established. Over this time
one had become out-dated and five were added. These datasets
included data from nine countries (Sweden, Spain, Ukraine,
Canada, Greece, UK, Netherlands, Portugal, and India). They
included data from 3.8 million primary care patients, of whom
800,000 were patients with asthma and 216,000 were patients
with COPD. Appendix 1 lists the datasets and their key features.
Several were large routine primary care datasets (HHR, OPCRD,
CCPSN), others were cohort studies (Praxis, BLISS, rural Crete) and
pragmatic clinical trials in primary care: Bocholtz study. Ten of the
datasets were used in at least one UNLOCK study.
All datasets included some common variables such as:
diagnosis, patient demographics; patient reported outcomes
including health status and symptoms; spirometry; prescribed
medication; exacerbations and smoking status. Some also
included data on physician demographics, vaccinations, patient
socioeconomic status and secondary care use.
The online questionnaire asked the UNLOCK Group participants
about charges for using the data, ownership, governance and
requirements for ethical approval for the datasets to which they
had access for UNLOCK purposes. See Table 3 for a breakdown of
results. For the majority of datasets there is no charge (57.1%) and
where charges are applied this depends on the type of study
(19%). Ethical approval requirements for using the datasets vary.
The most common model (33.3%) is that ethical approval was
secured at the beginning of the data collection and the data can
be analysed and the anonymised results shared for new studies
without seeking new approvals. The majority of the datasets are
owned by the research institute (28.6%) or the practice that
collects the data (23.8%). Governance arrangements for the
datasets differ, with the most common model being governance
by a committee (33.3%). Because of the variation of governance
arrangements in place for these datasets, the UNLOCK participants
decided it was not feasible to proceed with their original intention
of pooling datasets. Instead they agreed to undertake data
Table 1. The UNLOCK Group chronology of key developments (2010–2015)
Year UNLOCK meetings Key developments Publications
2010 June 2010– September 2010 Initial meeting agreed concept and confirmed support
Extended meeting to agree how to work
Potential research questions discussed
UNLOCK Abstract in Primary Care Respiratory
Journal, 2010
2011 May 2011–September 2011 Three initial UNLOCK Group studies agreed and start
Fundraising gets underway
2012 April 2012 First Novartis grant of €60,000
Agreement of small grants to support each UNLOCK study
Project to develop a common syntax for recoding agreed as
Rosetta
Agreement to extend the UNLOCK Group to include asthma
2013 March 2013 May 2013
November 2013
Project manager appointed
Niels Chavannes becomes the UNLOCK Group Chairperson
UNLOCK Group only spaces on IPCRG web platform launched
UNLOCK Steering Committee formed
In depth discussion of block to progress and how to
overcome these
Agreement for UNLOCK Researcher
Second Novartis grant of €140,000
UNLOCK studies on morning symptoms, comorbidities,
asthma RCT validity and implementation of COPD treatment
agreed
Lancet Letter “GOLD COPD categories are
not fit for purpose in primary care”, March
2013
2014 May 2014–September 2014 UNLOCK Group Researcher starts
UNLOCK Group study guidance prepared
UNLOCK Group study on cost effectiveness of COPD and
asthma treatment was endorsed
UNLOCK Group study on implementation of COPD treatment
stopped
UNLOCK study published in PLOS ONE
2015 May 2015–September 2014 UNLOCK Group Researcher extended for an additional year
UNLOCK Group study on ACOS agreed
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analysis separately using the same agreed analytical method for
each study and then to pool findings.
UNLOCK studies
By November 2016 eight studies initiated by the UNLOCK Group
had result in publications. These are listed in Table 4. Ideas for
additional studies were regularly discussed at UNLOCK meetings.
A further seven study proposals were presented by participants in
the UNLOCK Group, given provisional support, discussed at
several UNLOCK meetings but were not ultimately pursued. One
study idea was taken forward outside of the UNLOCK Group by
one of the participants with other partners. This raised the
challenge of intellectual property of ideas, reinforcing the need for
building trust between the UNLOCK Group participants and for
agreeing modus operandi. As a result a document specifying
principles of engagement for participation in the UNLOCK Group
was developed by the UNLOCK Steering Committee. These were
distributed to all UNLOCK participants, although no formal
signature was required.
Participants’ perceptions of the UNLOCK Group
Interviews were held with 12 key informants to identify their initial
motivations to become involved with the UNLOCK Group and to
determine what they wanted to achieve through their involve-
ment. The most frequently cited motivation was to improve
understanding of the primary care perspective and real world
research, which six informants mentioned. The opportunity to
learn from other countries (n= 5); the social aspect of collabora-
tion (n= 5); the potential to improve patient outcomes (n= 3);
and the ability to add power to existing data (n= 2) were also
relevant factors.
Informants were asked if they thought the UNLOCK Group was
achieving its primary purpose, to provide evidence to underpin
the primary care approach to diagnosis, assessment and broad
management strategies. All said the UNLOCK Group had worked
within this purpose, although seven said they thought it was a
long term and ambitious goal.
Seventy-nine percent of respondents (15/19) of the online
questionnaire perceived the UNLOCK Group to be “very effective”
or “effective” in its primary purpose, while the remaining 21
percent (4/19) said they thought it had “not been very effective.”
Respondents were also asked to rate what they considered to be
the main successes of the UNLOCK Group from a list of pre-
specified responses. As shown in Table 5, the generation of ideas
for progression outside UNLOCK, and bringing together collea-
gues from different countries, were rated most highly as the main
successes of the Group, followed by the UNLOCK studies.
All key informants were also asked an open question about
what they consider to be the main successes of the UNLOCK
Group. The themes raised by more than one informant in order of
their popularity were:
● The UNLOCK Group studies that have been completed (10/12).
● An inclusive and sustained network (9/12).
● Raising the profile and credibility of real world research (7/12).
Table 2. Summary of the UNLOCK Group participants and their participation
Name of individual Research (R) or clinical
(C) role or both (R &C)
Country Number of UNLOCK Group
meetings participated in
Number of UNLOCK Group
studies to which data was
contributed
1 Oleksii Korzh R &C Ukraine 0 1
2 Ana Moran C Spain 3 0
3 Andrew Cave R Canada 7 0
4 Antonius Schneider R Germany 1 0
5 Arnulf Langhammer R &C Norway 5 0
6 Bjorn Stallberg R &C Sweden 13 4
7 Bruce Kirenga R &C Uganda 1 0
8 Job van Boven R Spain/ Netherlands 2 2
9 Barbara Yawn R USA 1 0
10 David Price R &C UK/Singapore 8 4
11 Komalti Apte R &C India 2 0
12 Janwillem Kocks R &C Netherlands 10 6
13 Jaime Correia de Sousa R &C Portugal 8 1
14 Javiera Corbalan C Chile 2 0
15 Karin Lisspers R &C Sweden 10 4
16 Lynn Josephs R UK 5 0
17 Miguel Roman Rodriguez C Spain 8 2
18 Niels Chavannes R &C Netherlands 13 7
19 Peymane Adab R UK 2 1
20 Ioanna Tsiligianni R &C Greece 11 4
21 Rachel Jordan R UK 7 1
22 Rupert Jones R &C UK 8 1
23 Stefan Karrasch R Germany 1 0
24 Thys van der Molen R &C Netherlands 10 6
25 Mike Thomas R UK 8 1
26 Alan Crockett R Australia 1 0
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● Successfully working across countries (6/12).
● The ideas generated (3/12).
Key informants were also asked to describe the impact of the
UNLOCK Group’s work. The themes raised by more than one
informant in order of their popularity were:
● The development of a network for primary care research
across countries (9/12).
● Building for future work (4/12).
● Proving international research in primary care could be done
(3/12).
● Not possible to say without reviewing the studies in detail (2/
12).
● The impact of UNLOCK Group had been limited (2/12).
The majority of key informants interviewed stated that progress
had been slower than expected. When asked about the main
problems, the majority (7/12) indicated that the UNLOCK Group
wasn’t a priority for the participants because of the demands of
their main clinical and/or research role). Half of the informants also
said data differences had hampered research output. Other issues
raised were: the extent to which research questions were being
driven by the availability of data; whether the UNLOCK Group’s
research questions could best be answered by combining
different, heterogeneous datasets from different countries as
opposed to a large dataset from a single source; an over-reliance
on data from three countries; inadequate resources to progress
studies; a tendency amongst participants to generate ideas rather
than carry studies through to completion; not enough time in
meetings; difficulties coordinating study contributors; ethical and
cultural barriers; language differences; lack of leadership from the
UNLOCK Steering Committee; delineating what is UNLOCK Group
when participants have multiple roles; and having too many small
datasets.
The online questionnaire asked UNLOCK Group participants to
agree or disagree with a range of statements about UNLOCK
Group meetings. All respondents either agreed or agreed strongly
with the statement “I find UNLOCK Group meetings really useful
because I get to hear about the research my colleagues are doing.”
There was also majority agreement with the statement “I find
UNLOCK Group meetings really useful because I learn about the
clinical consultation, essential data collection and coding in other
countries which helps me understand similarities and differences
better.” No respondents agreed with the statement “I do not
attend meetings as I do not find UNLOCK Group meetings useful.”
Table 6 shows the statements and average response, with higher
scores indicating stronger levels of agreement.
Action to overcome challenges
Analysis of the minutes of UNLOCK Group meetings showed some
studies were discussed regularly at UNLOCK Group meetings over
four years. Meeting minutes also highlighted that participants
discussed how to progress studies more effectively on several
occasions. Over the years 2010–2016, participants in the UNLOCK
Group introduced new ways of working to overcome barriers to
progress. These included:
● Arranging meetings to coincide with existing conferences.
● Using PhD students to progress studies.
● Paying small grants to lead authors to facilitate studies.
● Setting up a private discussion space on the IPCRG web
platform.
● Dedicated project management.
● Setting up a Steering Committee.
● Testing the feasibility of a single data exchange portal.
● Funding a part-time researcher managed by a Steering
Committee member.
● Defining processes and templates for developing and
implementing an UNLOCK Group study.
Interviews with key informants revealed adoption of a prag-
matic approach to solving problems as they arose. When asked if
this approach to had been effective, the broad consensus was
“partly”. Reasons suggested why these had not been more
effective included:
● The researchers collaborating on UNLOCK Group studies are
not located in the same place.
Table 3. Arrangements for charging, ownership, governance, and
ethical approval requirements for use of data used by the UNLOCK
Group
Number Percentage of
responses
Is there a charge for suing the data for UNLOCK Group studies
Yes, there is a fixed charge for using the data 0 0.0
Yes, there is a charge for using the data that
depends on the type of study
4 19.0
Sometimes there is a charge for using the
data but this can be waived for UNLOCK
Group studies
2 9.5
No charge for using the data 12 57.1
Other 3 14.3
Who owns the data
The regional health authority 3 14.3
The national health authority 1 4.8
A research institute 6 28.6
The practice that collects it 5 23.8
A private company 1 4.8
Ownership arrangements are unclear 1 4.8
Other 4 19.0
Who is responsible for the governance of the data
The regional health authority 4 19.0
The national health authority 0 0.0
A research institute 4 19.0
The practice that collects it 2 9.5
A committee 7 33.3
Governance arrangements are unclear 1 4.8
Other 3 14.3
Requirements for ethical approval for use of the data
Ethical approval was secured at the
beginning of the data collection and the
data can be shared for new studies without
seeking new approvals
3 14.3
Ethical approval was secured at the
beginning of the data collection and the
data can be analysed and the anonymised
results shared for new studies without
seeking new approvals
7 33.3
Ethical approval was secured at the
beginning of the data collection and the
data can be analysed and the anonymised
results shared but new ethical approval is
required for new study questions
3 14.3
New ethical approvals are required every
time the data is used for a new study
3 14.3
Ethical arrangements are unclear 1 4.8
Other 4 19.0
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● There are lots of different expertise needed to progress the
UNLOCK Group studies including methodology, epidemiology,
statistics, project management, fundraising, writing and it is
not possible to get all of these from one person but the
UNLOCK Group does not have the resources to fund a team.
● The UNLOCK Group meetings are big and fast which can be a
barrier to detailed discussions on study findings.
● While new processes have led to the improvement of the
articulation of study ideas into written protocols, these still
need to be improved.
Future development of the UNLOCK Group
Interviews with key informants sought to clarify what lessons of
the UNLOCK Group’s work could be applied to future studies.
Three primary themes raised by more than one informant in order
of their popularity were:
● Do not try to pool data as it is not feasible (5/12).
● Do not use existing data as a starting point (4/12).
● Improve organisation and professionalism (3/12).
Respondents to the online questionnaire (n= 19) were asked
what they thought were the priorities for future UNLOCK Group
studies. The topics prioritised by most respondents were COPD
management in primary care (prioritised by 95% of respondents,
comorbidities (74%), asthma management in primary care (68%)
and COPD diagnosis in primary care (53%). Respondents were also
asked to indicate whether they agreed with a number of pre-
specified options for the development of the UNLOCK Group. The
three options which scored the most support were “it needs new
countries to join to bring additional data from more diverse
contexts” (supported by 53% or respondents), “UNLOCK Group
participants need to make better use of their existing data by
doing more studies” (53%) and “the UNLOCK Group participants
need to focus more on supporting each other and new
participants to create and improve datasets” (47%).
Table 4. UNLOCK Group publications as of November 2016 Study
Lead author Co-authors Publications/status
UNLOCK: uncovering and noting long-term
outcomes in COPD to enhance knowledge
Niels H
Chavannes
Bjorn Stallberg, Rupert C. M. Jones, Ioanna
G. Tsiligianni, Karin Lisspers, Thys van der
Molen, JanWillem H. Kocks, Miguel
Roman, Ana Moran, Arnulf Langhammer,
Alan Crockett, Andrew Cave, Sian Williams
UNLOCK Abstract published in Primary
Care Respiratory Journal, 2010
Multi-component assessment of chronic
obstructive pulmonary disease: an evaluation
of the ADO and DOSE indices and the global
obstructive lung disease categories in
international primary care data sets
Rupert C Jones David Price, Niels H Chavannes, Amanda J
Lee, Michael E Hyland, Björn Ställberg,
Karin Lisspers, Josefin Sundh, Thys van
der Molen and Ioanna Tsiligianni
Article published in npj Primary Care
Respiratory Medicine, April 2016; Abstract
in Primary Care Respiratory Journal, April
2012; Lancet Letter “GOLD COPD
categories are not fit for purpose in
primary care”, March 2013
Primary care patients compared with large
pharmaceutically-sponsored COPD studies:
an UNLOCK validation study
Annemarije L.
Kruis
Bjorn Stallberg, Rupert C. M. Jones, Ioanna
G. Tsiligianni, Karin Lisspers, Thys van der
Molen, JanWillem H. Kocks, Niels H.
Chavannes
Article published in PLOS ONE, March
2014
Are pharmacological randomised controlled
clinical trials relevant to real-life asthma
populations? An UNLOCK study from the
IPCRG
Karin Lisspers Pedro Teixeira, Coert Blom, Janwillem
Kocks, Björn Ställberg, David Price and
Niels Chavannes
Protocol published in npj Primary Care
Respiratory Medicine, April 2016
Predictors of cost-effectiveness of selected
COPD treatments in primary care: an
UNLOCK study from the IPCRG
Job FM van
Boven,
Miguel Román-Rodríguez, Janwillem WH
Kocks, Joan B Soriano, Maarten J Postma
and Thys van der Molen
Protocol published in npj Primary Care
Respiratory Medicine, April 2016
The prevalence of night and morning
symptoms in primary care COPD patients:
how do they relate to COPD health status
and disease severity?
Ioanna G.
Tsiligianni
Esther, Metting Thys van der Molen,
JanWillem H. Kocks, Niels H. Chavannes
Published in npj Primary Care Respiratory
Medicine, July 2016
The prevalence of comorbidities in COPD
patients and their impact on the quality of
life and COPD symptoms in primary care
patients
Björn Ställberg Pedro Teixeira, Coert Blom, JanWillem
Kocks, Karin Lisspers, David Price and
Niels Chavannes, Job van Boven, Miguel
Roman-Rodriguez, Oleksii Korzh, Rachel
Jordan
Protocol published in npj Primary Care
Respiratory Medicine, November 2016
Fostering the exchange of real life data
across different countries to answer primary
care research questions: an UNLOCK study
from the IPCRG
Liza Cragg Siân Williams, Thys van der Molen, Mike
Thomas, Jaime Correia de Sousa, Niels H.
Chavannes
Protocol published in npj Primary Care
Respiratory Medicine, September 2016
Table 5. UNLOCK main successes
Answer options: main successes Rating
Average
Generating new ideas for research questions
that are taken forward outside the UNLOCK
Group
4.05
Bringing together colleagues from different
countries
3.95
The UNLOCK Group studies that have been
completed
3.84
Creating a forum to share data issues with
colleagues informally
3.79
Encouraging the development of new datasets 3.68
Others 1.68
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DISCUSSION
Main findings
Challenges and constraints. This study revealed three primary
themes that influenced the challenges and constraints experi-
enced by the UNLOCK Group between 2010–2016. The first was
data constraints which impacted on the comparability of data.
These constraints included: variable dataset size and accuracy with
small, detailed datasets from cohort studies being more accurate
than large routine datasets; datasets including different variables
or the same variables using different codes and definitions; and
the availability of incentives in some countries for diagnosis and
treatment. These data comparability challenges raise concerns
about the internal validity of studies. As a result, discussion of
studies at the UNLOCK Group meetings increasingly stressed the
importance of the UNLOCK Group studies comparing different
countries’ experiences, rather than combining data to achieve
more power. There was also a perception amongst participants of
constraints due to governance and ethical requirements for using
some datasets. In practice it is not clear that these constraints
prevented the use of data, although they sometimes caused
delays. Not having required data variables was more of a
constraint for participants contributing to studies. In addition,
contributing data to a study required time from participants.
The second theme was challenges that arose from participants
from several countries working as a group including: different
expectations of how meetings should be used; difficulties in using
English as the working language for some non-native English
speakers; using different processes for developing study propo-
sals; and cultural differences in how to undertake methodological
scrutiny without appearing overly critical.
The third theme of constraints related to participants’ lack of
time. The UNLOCK Group participants have many demands on
their time due to their main clinical and/or research roles, and
participation in the UNLOCK Group is entirely voluntary. The
voluntary and collaborative nature of the UNLOCK Group meant
studies progress as fast as the slowest responder. If there were
problems with studies they were brought back to the next
meeting for further discussion. This led to some frustration that
some studies were not progressing fast enough, with a sense that
some studies were repeatedly discussed at the UNLOCK Group
meetings.
Strategies to overcome challenges and constraints
The UNLOCK Group participants adopted various strategies to
overcome challenges using a pragmatic approach to solving
problems as they arose. These strategies were partly effective but
had their own limitations. In addition to data cleaning and
validation, templates for developing and implementing an
UNLOCK Group study were developed to ensure quality and
consistency. While this enabled improvement in proposals for the
later studies, protocols for some of earlier studies were not
sufficiently well defined. This led to one study being abandoned
after significant time and work. To overcome time constraints the
UNLOCK Group participants used PhD students and more junior
researchers to progress studies. Although this greatly facilitated
the progress of the UNLOCK Group studies, it was only an option
for the UNLOCK Group participants affiliated to academic
institutions with PhD students engaged in primary care respiratory
research, which remains a small academic discipline. The UNLOCK
Group participants also agreed to make available small grants to
lead authors to facilitate studies. These enabled lead authors to
lever in additional resources from their own institutions where
available, but were not adequate to cover the costs of their own
time. A Steering Committee was convened to take decisions
outside meetings but this did not have a role in progressing
studies. Later a part-time researcher managed by a Steering
Committee member was recruited. However, this did not speed
up progress as much as anticipated, perhaps because the
researcher was not co-located with the first authors. A part-time
project manager was engaged which improved communication
and co-ordination between participants. To facilitate progress
outside meetings a private discussion space on the IPCRG web
platform was set up. However, most participants preferred face-to-
face interaction.
Main successes and impacts
In the six year period that this study covers, the UNLOCK Group
undertook nine studies on the diagnosis and management of
COPD, asthma and ACOS in primary care. These had resulted in
eight published journal articles (with more in press) and many
presentations at leading international conferences by mid-2016. In
addition to these outputs, the UNLOCK Group developed a
network of primary care researchers across 15 very different
countries which was sustained for over six years. This brought
access to data from 3.8 million primary care patients across 10
countries, creating potential for multi-country studies involving
large numbers of patients.
The UNLOCK Group participants broadly agreed that the impact
of the studies on practice was low. However, translating research
into clinical practice is widely recognised as being extremely
Table 6. Perceptions of UNLOCK Group meetings
Answer options: UNLOCK Group meetings Disagree Neither agree nor
disagree
Agree Agree
strongly
I find UNLOCK Group meetings really useful because I get to hear about the research my colleagues
are doing
0 (0%) 0 (0%) 8
(42%)
11 (58%)
I find UNLOCK Group meetings really useful because I learn about the clinical consultation, essential
data collection and coding in other countries which helps me understand similarities and differences
better
1 (5%) 3 (16%) 7
(37%)
8 (42%)
I find UNLOCK Group meetings really useful because I reflect on how to improve dataset
management
4 (21%) 4 (21%) 6
(32%)
5 (26%)
I find UNLOCK Group meetings really useful because I get the opportunity to think about the
advantages and disadvantages of different coding approaches
5 (26%) 5 (26%) 5
(26%)
4 (22%)
I have used the learning at UNLOCK Group meetings to influence the design of electronic health
records in my practice/region/country
7 (37%) 5 (26%) 4
(21%)
3 (16%)
I would like to attend UNLOCK Group meetings but I am unable to prioritise attending them because
of other work commitments.
11 (58%) 2 (10.5%) 4
(21%)
2 (10.5%)
I do not attend meetings as I do not find UNLOCK Group meetings useful. 16 (84%) 3 (16%) 0
(0%)
0 (0%)
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complex, difficult and time consuming. Studies have found that it
takes around 17 years to translate research evidence into changes
in care that benefited patients.,7–9 Therefore, it would be overly
ambitious to expect the UNLOCK Group to have demonstrable
impact on clinical practice.
In addition, the participants described other significant impacts
that the UNLOCK Group has achieved. These included raising the
profile and credibility of real world research and proving it is
possible for an international collaboration to do primary care
research. The UNLOCK Group acted as a catalyst for the
development of new national primary care datasets that would
be fit for routine and research use. The UNLOCK Group datasets
are now being used to validate the first European COPD atlas. In
addition, it stimulated ideas and collaborations that have been
taken forward outside the UNLOCK Group. These include
collaborations on significant externally funded research projects;
the UNLOCK Group participants acting as co-authors to other
participants on studies; the UNLOCK Group participants providing
external supervision for PhD students from each other’s institu-
tions; and collaborations at research conferences and symposia.
The slow progress with some of the UNLOCK Group’s studies
and the frustration that more had not be achieved is partly due to
the limitations inherent in the collaborative model, which relies on
voluntary participants. This means it is difficult to enforce
deadlines. The UNLOCK Group also relied on the skills and
capacities participants brought to lead studies, supplemented by a
part-time project manager and researcher. It became clear that
more specialist and dedicated expertise in epidemiology, meth-
odology, statistical analysis and medical writing was needed but
the UNLOCK Group did not have sufficient resources to fund a
team with these skills.
There was consensus among participants that some of the
frustration resulted from unrealistically high expectations about
what could be achieved in the beginning and that they were
learning by doing so identifying the challenges and constraints
had been part of the development process.
Specific challenges for primary care data
The UNLOCK Group participants interviewed said that many of the
challenges the Group experienced were common to other medical
and healthcare research, for example, consent, ethics, data
ownership. However, they also suggested there were some
specific challenges to fostering the exchange of primary care
data in comparison to other datasets, such as secondary care.
These included the large number of conditions that are diagnosed
and managed in primary care which require very many different
codes and different primary care coding systems. In addition,
some participants suggested routine data collected in primary
care may be of more variable quality than that collected in
secondary care, with the lack of trained coders, the range of codes
and payment incentives for quality indicators impacting on data
accuracy. There were also particular ethical and governance issues
involved in using routine data because it has not been collected
for research purposes. Some informants said that variations in the
way primary care is structured and incentivised between countries
are greater than other areas of speciality and that there is less
capacity and expertise for research in primary care than in other
areas.
Interpretation of findings in relation to previously published work
Recent work has highlighted that large scale collection and
analysis of routine data, including patients’ experiences and
outcomes, has become common place in health care systems
although these large datasets are not used to their full potential.10
Research has shown that multiple large databases can be used
effectively to increase power, to assess outcomes, or to study
diverse populations and has proposed conceptual models to
facilitate the process of analyzing data from multiple databases.11
Research has also demonstrated that real world data has an
important role to play in the evaluation of burden of disease,
treatment patterns, compliance, persistence, and health outcomes
of different treatments.12
This study adds to this work by demonstrating the value of
researchers and clinicians collaborating to share real world data
across regional and country borders to answer research questions
studies and by exploring the factors that enable such collabora-
tion in practice. It also identifies the knowledge developed by the
UNLOCK Group to improve the effectiveness of future collabora-
tions and studies.
Strengths and limitations of this study
Limitations to this study and measures taken to mitigate these
include:
● The interviews and analysis were carried out by the UNLOCK
Group project manager, who was funded by the project and
therefore had a potential conflict of interest in demonstrating
positive outcomes. This was mitigated by peer review of all
questionnaires and presentation of the draft findings at an
UNLOCK Group meeting. In addition, an abstract on the
interim findings was peer-reviewed and presented at the
IPCRG 8th World Conference, where independent judges
voted it one of the top three abstracts out of 137.
● Some participants in early UNLOCK Group meetings who
stopped being actively involved did not complete the online
questionnaire therefore the motivations and challenges of
those who chose to leave is not fully documented.
● The findings show participants in the interviews and ques-
tionnaires had a very positive experience of the UNLOCK
Group meetings as a safe place to explore ideas and to
network with colleagues with similar mind-sets. There is a risk
this reflects “groupthink” in these meetings, whereby partici-
pants try to minimise conflict and reach a consensus.13
However, this study also included analysis of minutes of
Box 1: Case studies exploring factors for successful UNLOCK
studies
The UNLOCK Group study “Primary care COPD patients compared with large
pharmaceutically-sponsored COPD studies: an UNLOCK validation study” was
initiated in September 2011. Final results were presented in May 2013 and it was
published in PLOS ONE in March 2014.6 Despite the fact that it included data from
seven UNLOCK datasets, it was completed and published promptly. Critical
factors for which enable this study to be successful concluded are:
The central hypothesis of the study was clearly articulated at the start;
The study was of identifiable clinical relevance which motivated the study
team;
The UNLOCK Group participant leading the study identified a dedicated
research team in their own institution to undertake the analysis. This included
a goal-oriented PhD student whom they directly supervised;
With the support of the UNLOCK Group participant, this research team were
able to mobilise their counterparts in partner institutions to ensure data was
provided promptly, rather than relying exclusively on the UNLOCK Group
participants themselves.
In contrast, the UNLOCK Group study “Comparing GOLD stages between
countries” was initiated in September 2011. Interim analysis of four datasets was
undertaken and results presented in March 2013. Interim findings were discussed
regularly at UNLOCK Group meetings through 2014 and 2015 with suggestions
made for the improvement of the findings. The study was finally abandoned in
September 2016 when considered no longer viable. Reasons identified include:
There were problems with internal validity due to combining large and small
datasets and with differences in the definitions of variables between datasets;
The lead UNLOCK Group participant did not have a research team on site to
support the analysis;
The research question did not motivate enough researchers to participate;
Because the study took so long, its clinical relevance was reduced by changes
to management guidelines.
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meetings which demonstrate robust discussion and chal-
lenges to ideas and data presented.
● Individuals who have received documents related to the
UNLOCK Group but who have not actually participated were
not invited to complete the online questionnaire. Therefore,
the study does not attempt to explore why some invited
researchers did not participate.
Implications for future research, policy, and practice
Better use and integration of routinely collected health data to
develop population medicine approaches, risk stratification and
segmentation to improve outcomes is essential. For example, high
need high cost patients who experience a variety of complex
health and functioning problems are among the 5% of patients
who account for 50% of health care spending in the USA. Primary
care data are essential to understanding how to better meet their
health needs.14 In addition, primary care data capture multi-
morbidities and consequently can help answer important ques-
tions on the diagnosis and management of patients with multi-
morbidities. For example, a recent clinical audit in the UK found
80% of patients with a COPD diagnosis had a comorbidity.15 It can
also help understand how best to address the determinants of
health which are currently addressed inadequately by many
healthcare providers.16
Research funders have recently prioritized the challenge of
finding ways to break down data silos and translate data into
actionable information.17 There is consensus in policy documents
and research agendas that primary care has a key role in the fight
against NCDs.18–20 Consequently, guidelines and pathways need
to reflect primary care experience, priorities and needs, including
the generation and incorporation of evidence about primary care
approaches to diagnosis, assessment and effective management
strategies.21 In addition, policy makers and funders have identified
the need to improve the quality and availability of primary care
data.22 Recent European health policy has also called for better
use of existing data to formulate policies to improve the health of
individuals and populations.23,24
At the same time, there is increased emphasis on the need for
data to be shared between researchers to accelerate analysis and
learning. However, challenges in building the culture and
resources needed to support data sharing are considerable and
include concerns that researchers in resource-poor settings will
lose out to better-resourced researchers, fears that increased data
sharing will create unacceptable risks for patients and the costs in
terms of money and time of data sharing.25
The experience of the UNLOCK Group has shown that individual
relationships and trust are strong motivator for individuals to
collaborate. However, personal relationships and individual
motivation alone are unlikely to be sufficient to deliver high
quality research over a sustained period without significant
dedicated resources. Individual professionals with experience of
real world practice and access to data often lack the time and
expertise to undertake research themselves. However, research
institutions that have the resources and expertise do not have the
same experience of real world practice. This means collaborations
between those with access to the data and experience of practice
and researchers need to be better supported financially to enable
capacity building and knowledge exchange.
The UNLOCK Group has also shown there are complex issues in
sharing data from primary care across countries including dataset
size, representativeness, coding accuracy, significance of variables.
There is “no one size fits all” solution for these. There are also
ethical and governance issues which can make accessing routine
data time-consuming and difficult. This means the research
question needs to be right, requiring international comparison
rather than pure power and a strong interest from collaborators.
Data sharing is more complex that a single dataset study so
methodological and statistical expertise is required.
Primary care data offers unique opportunities to explore
symptoms, diagnosis and patient reported outcomes. Rather than
merely supplementing typical approaches of disease specific
guidelines, pathways and evidence generation, it can contribute
to the development of newer concepts of functioning, health and
disability with better capture patient perspectives and multi-
morbidities. This reflects developments in family medicine
teaching and can support shared decision-making. However,
there are some specific methodological challenges in using this
data. More work is needed to support the standardisation or
datasets, including dictionaries of codes and definitions. Finally,
the coordination and time that international collaborations such
as the UNLOCK Group require should not be underestimated.
CONCLUSIONS
From 2010 to 2016 the UNLOCK Group demonstrated a strong
interest and willingness to engage in international research
collaborations amongst primary care researchers and clinicians.
This reflected a belief that shared learning between countries is
important and primary care research has a unique value, including
capturing comorbidities, patient reported outcomes and using a
person-centred approach. The collaboration completed several
important studies and achieved a wider impact by demonstrating
that real world research across middle and high income countries
is feasible. It also generated indirect benefits by instigating new
research collaborations between institutions and individuals and
new datasets. The complexity of sharing data across countries and
coordinating the UNLOCK Group’s work meant that progress was
slower than participants anticipated. However, most participants
remained committed and confident that with the right support
and financial and human resources it was possible to provide
valuable insights and generate learning between countries on the
diagnosis, treatment and prevention of respiratory diseases in the
community which could be used to inform the production of
better guidance and pathways for practising clinicians.
METHODS
The study used a mixed methods design including the following
● A review of documents related to the UNLOCK Group was undertaken
to develop the chronology of key events; to identify research ideas
and how these progressed into studies; to identify challenges
identified by the Group and action proposed to overcome these;
and to identify who participated in the Group over the 6 years
covered. The review identified documents on the IPCRG web platform
related to the UNLOCK Group meetings and published articles
produced by the UNLOCK Group. A list of the documents identified
was then checked with the minutes of UNLOCK Group meetings to
ensure all documents that had been used at those meetings were
included. In addition, the UNLOCK Group Chairperson and the IPCRG
executive director checked the list of documents to ensure none had
been omitted. The review of documents was carried out by the
UNLOCK Group project manager.
● A structured online questionnaire for UNLOCK Group participants was
undertaken using Survey Monkey in January and February 2016. The
questionnaire explored: the roles of participants; the data to which
they have access; perceptions of the strengths of the UNLOCK Group;
obstacles that limit participation in UNLOCK studies; how these can be
overcome; and ideas about future priorities. The questionnaire was
designed by the UNLOCK Group project manager and the IPCRG
executive director. It was tested by two UNLOCK members and then
refined based on their feedback. Twenty-seven participants in the
UNLOCK Group were invited to complete the questionnaire. Of these
21 responded; a response rate of 77%. However, not all questions
were completed by all respondents. Analysis of the responses to the
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questionnaire were based on the response rate for each question.
Responses to the online questionnaire were analysed by comparing the
percentage of respondents who gave each answer or agreed and dis-
agreed with suggested statements and by rating participants’ prioritisa-
tion of suggested themes. Analysis was undertaken by the UNLOCK
Group project manager and checked by the IPCRG executive director.
● Structured interviews with 12 UNLOCK Group participants, including
Steering Committee members and lead authors for the UNLOCK
Group studies, to explore the barriers to undertaking and completing
these studies and how they can be overcome and the successes,
impacts and the learning to date. The informants’ responses to each
question were coded and thematically analysed to identify the key
issues from the perspective of the participants. The frequency with
which each issue was raised by informants was also analysed to
explore to what extent perspectives were shared. Analysis was
undertaken by the UNLOCK Group project manager and checked by
the IPCRG executive director.
● A review of the datasets held by current participants in the UNLOCK
Group, how these have changed over time and how many of these
datasets have been used for the UNLOCK Group studies. Each
participant in the UNLOCK Group was requested to provide
information on defined characteristics of their dataset in September
2015. The number of patients included in these datasets and the
variables they collected were compared with those available to the
UNLOCK Group in 2012. Analysis was undertaken by the UNLOCK
Group project manager and checked by the IPCRG executive director.
More details of methods can be found in the published study protocol.26
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